Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis

Schizophrenia is a chronic disabling disorder for which current treatments are only partially effective. While the evaluation of novel interventions is a high priority, loss to follow-up is a major threat to validity.

Source: Schizophrenia Research - August 25, 2017 Category: Psychiatry Authors: Kyaw Sint, Robert Rosenheck, Delbert G. Robinson, Nina R. Schooler, Patricia Marcy, John M. Kane, Kim T. Mueser, Haiqun Lin, other RAISE ETP Investigators Source Type: research